Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials - Fang, W; Yang, Y; Ma, Y (Lancet Oncol, 2018)